Research ArticleBRAIN
Differentiation of Low-Grade Oligodendrogliomas from Low-Grade Astrocytomas by Using Quantitative Blood-Volume Measurements Derived from Dynamic Susceptibility Contrast-Enhanced MR Imaging
Soonmee Cha, Tarik Tihan, Forrest Crawford, Nancy J. Fischbein, Susan Chang, Andrew Bollen, Sarah J. Nelson, Michael Prados, Mitchel S. Berger and William P. Dillon
American Journal of Neuroradiology February 2005, 26 (2) 266-273;
Soonmee Cha
Tarik Tihan
Forrest Crawford
Nancy J. Fischbein
Susan Chang
Andrew Bollen
Sarah J. Nelson
Michael Prados
Mitchel S. Berger

References
- ↵Lopes M, Laws EJ. Low-grade central nervous system tumors. Neurosurg Focus 2002;12:1–4
- ↵Sasaki H, Zlatescu MC, Betensky RA, et al. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade “oligodendroglioma” J Neuropathol Exp Neurol 2002;61:58–63
- ↵
- ↵Pomper MG, Port JD. New techniques in MR imaging of brain tumors Magn Reson Imaging Clin N Am 2000;8:691–713
- ↵Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings Radiology 1994;191:41–51
- ↵Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging Radiology 1999;211:791–798
- ↵Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas AJR Am J Roentgenol 1998;171:1479–1486
- ↵Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas Clin Cancer Res 2000;6:2189–2200
- ↵Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendroglimoas AJNR Am J Neuroradiol 2004;25:214–221
- ↵Kleihues P, Sobin LH. World Health Organization classification of tumors Cancer 2000;88:2887
- ↵Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas Cancer 1997;79:1381–1393
- ↵Morrison PF, Chen MY, Chadwick RS, Lonser RR, Oldfield EH. Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics Am J Physiol 1999;277:R1218–1229
- Groothuis DR. The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery Neuro-oncol 2000;2:45–59
- ↵
- ↵Prados MD, Levin V. Biology and treatment of malignant glioma Semin Oncol 2000;27:1–10
- ↵Wild-Bode C, Weller M, Wick W. Molecular determinants of glioma cell migration and invasion J Neurosurg 2001;94:978–984
- Smith JS, Jenkins RB. Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications Front Biosci 2000;5:D213–231
- Fathallah-Shaykh HM, Zhao LJ, Mickey B, Kafrouni AI. Molecular advances to treat cancer of the brain Expert Opin Investig Drugs 2000;9:1207–1215
- Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 1998;90:1473–1479
- ↵Bogler O, Huang HJ, Kleihues P, Cavenee WK. The p53 gene and its role in human brain tumors Glia 1995;15:308–327
- ↵Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas J Clin Oncol 2000;18:636–645
- ↵
- ↵
- ↵Varlet P, Guillamo JS, Nataf F, Koziak M, Beuvon F, Daumas-Duport C. Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival Neuropathol Appl Neurobiol 2000;26:379–389
- ↵Christov C, Adle-Biassette H, Le Guerinel C, Natchev S, Gherardi RK. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas Neuropathol Appl Neurobiol 1998;24:29–35
- ↵
- ↵
- ↵Schiffer D, Dutto A, Cavalla P, et al. Prognostic factors in oligodendroglioma Can J Neurol Sci 1997;24:313–319
- ↵Mork SJ, Halvorsen TB, Lindegaard KF, Eide GE. Oligodendroglioma: histologic evaluation and prognosis J Neuropathol Exp Neurol 1986;45:65–78
In this issue
Advertisement
Differentiation of Low-Grade Oligodendrogliomas from Low-Grade Astrocytomas by Using Quantitative Blood-Volume Measurements Derived from Dynamic Susceptibility Contrast-Enhanced MR Imaging
Soonmee Cha, Tarik Tihan, Forrest Crawford, Nancy J. Fischbein, Susan Chang, Andrew Bollen, Sarah J. Nelson, Michael Prados, Mitchel S. Berger, William P. Dillon
American Journal of Neuroradiology Feb 2005, 26 (2) 266-273;
Differentiation of Low-Grade Oligodendrogliomas from Low-Grade Astrocytomas by Using Quantitative Blood-Volume Measurements Derived from Dynamic Susceptibility Contrast-Enhanced MR Imaging
Soonmee Cha, Tarik Tihan, Forrest Crawford, Nancy J. Fischbein, Susan Chang, Andrew Bollen, Sarah J. Nelson, Michael Prados, Mitchel S. Berger, William P. Dillon
American Journal of Neuroradiology Feb 2005, 26 (2) 266-273;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making
- 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas
- Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas
- Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas
- The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: An 11C-(R)PK11195 PET Imaging and Neuropathology Study
- Semi-automated and automated glioma grading using dynamic susceptibility-weighted contrast-enhanced perfusion MRI relative cerebral blood volume measurements
- Imaging Characteristics of Oligodendrogliomas That Predict Grade
- Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours
- Biology, genetics and imaging of glial cell tumours
- Correlation of MR Relative Cerebral Blood Volume Measurements with Cellular Density and Proliferation in High-Grade Gliomas: An Image-Guided Biopsy Study
- Enhancing Fraction in Glioma and Its Relationship to the Tumoral Vascular Microenvironment: A Dynamic Contrast-Enhanced MR Imaging Study
- Spin-Echo Echo-Planar Perfusion MR Imaging in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Distinguishing Solitary Metastases from Primary Glioma
- Analysis of 11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity
- Histogram Analysis of MR Imaging-Derived Cerebral Blood Volume Maps: Combined Glioma Grading and Identification of Low-Grade Oligodendroglial Subtypes
- Inclusion or Exclusion of Intratumoral Vessels in Relative Cerebral Blood Volume Characterization in Low-Grade Gliomas: Does It Make a Difference?
- Can Proton MR Spectroscopic and Perfusion Imaging Differentiate Between Neoplastic and Nonneoplastic Brain Lesions in Adults?
- Comparing Perfusion Metrics Obtained from a Single Compartment Versus Pharmacokinetic Modeling Methods Using Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade
- Low-grade gliomas in adults.
- Update on Brain Tumor Imaging: From Anatomy to Physiology
- Comparison of Microvascular Permeability Measurements, Ktrans, Determined with Conventional Steady-State T1-Weighted and First-Pass T2*-Weighted MR Imaging Methods in Gliomas and Meningiomas.
- Assessment of Diagnostic Accuracy of Perfusion MR Imaging in Primary and Metastatic Solitary Malignant Brain Tumors
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement